MarketPeel
Insider Trading Intelligence
HS

Hunter C. Smith

RYTM
CHIEF FINANCIAL OFFICER · RHYTHM PHARMACEUTICALS, INC. · CIK 0001636385
FILING MIX · LIFETIME35%/65%
BUYS
46
SELLS
84
TOTAL VALUE
$15.34M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
119,611
AVG SELL PX
$65.62
TRADE KIND
SHOWING 130 / 130
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
48 backtested trades · 8 horizons · 87 pending
Forward-return performance of every backtestable P/S trade by Hunter C. Smith, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d48+52.08%+0.40%+0.28%+0.12%-0.54%0.12
14d48+64.58%+0.02%+0.12%-0.10%-3.61%-0.03
30d48+75.00%-2.77%-1.74%-1.03%-6.97%-0.23
60d48+62.50%+3.81%+0.42%+3.39%-10.99%0.37
90d48+66.67%+5.88%+5.46%+0.41%-13.95%0.04
180d48(23 pending)+20.00%+57.23%+9.29%+47.94%+4.25%
1y48(28 pending)+0.00%+84.34%+20.86%+67.40%+54.88%
2y48(36 pending)+0.00%+245.52%+46.02%+199.50%+102.38%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RYTM · 119,611 shares · as of May 18, 2026
044,87489,747134,621179,494202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 46 buys / 84 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
3,000$17.87$53.6K119,611May 18, 2026May 20, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
3,00079,000May 18, 2026May 20, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
6,099$6.80$41.5K116,611Mar 2, 2026Mar 2, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,09991,401Mar 2, 2026Mar 2, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
585$103.28$60.4K110,512Feb 19, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,308$100.27$131.2K113,589Feb 19, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,692$100.92$170.8K111,897Feb 19, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
800$102.10$81.7K111,097Feb 19, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
200$103.84$20.8K114,897Feb 17, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
200$100.52$20.1K117,066Feb 17, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,200$99.42$119.3K117,266Feb 17, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
900$101.70$91.5K116,166Feb 17, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,069$103.00$110.1K115,097Feb 17, 2026Feb 19, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
400$97.67$39.1K119,366Feb 12, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
100$100.10$10.0K118,466Feb 12, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
800$98.99$79.2K118,566Feb 12, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
292$96.26$28.1K119,766Feb 12, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
100$100.85$10.1K120,058Feb 11, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,266$98.37$222.9K120,558Feb 11, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
37,50037,500Feb 11, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
400$99.44$39.8K120,158Feb 11, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Feb 11, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,913$102.66$196.4K123,624Feb 10, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
700$103.68$72.6K122,924Feb 10, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
100$104.76$10.5K122,824Feb 10, 2026Feb 12, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,381$106.06$358.6K125,537Feb 5, 2026Feb 6, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,500$104.74$157.1K130,665Feb 4, 2026Feb 6, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,000$106.60$106.6K129,665Feb 4, 2026Feb 6, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
747$107.67$80.4K128,918Feb 4, 2026Feb 6, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,60013,200Feb 1, 2026Feb 3, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
10,750$108.99$1.17M132,165Feb 1, 2026Feb 3, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,0620Feb 1, 2026Feb 3, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
10,41331,237Feb 1, 2026Feb 3, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,9254,925Feb 1, 2026Feb 3, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
26,000142,915Feb 1, 2026Feb 3, 2026View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
3,477$6.88$23.9K120,392Aug 13, 2025Aug 14, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,477$96.00$333.8K116,915Aug 13, 2025Aug 14, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
3,4770Aug 13, 2025Aug 14, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
24,6113,477Aug 12, 2025Aug 14, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
24,611$96.33$2.37M116,915Aug 12, 2025Aug 14, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
24,611$6.88$169.3K141,526Aug 12, 2025Aug 14, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
17,113$75.38$1.29M141,922Jul 9, 2025Jul 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
23,400$84.50$1.98M116,915Jul 9, 2025Jul 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
42,120$6.88$289.8K159,035Jul 9, 2025Jul 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,607$76.17$122.4K140,315Jul 9, 2025Jul 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
42,12028,088Jul 9, 2025Jul 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
6,986$6.88$48.1K116,915Jul 7, 2025Jul 8, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,98670,208Jul 7, 2025Jul 8, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
23,400$6.88$161.0K133,329May 30, 2025Jun 3, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,407$60.93$268.5K128,922May 30, 2025Jun 3, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
23,40077,194May 30, 2025Jun 3, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
18,993$61.52$1.17M109,929May 30, 2025Jun 3, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,215$57.22$126.7K109,929Feb 19, 2025Feb 19, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,60019,800Feb 16, 2025Feb 19, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
6,600112,144Feb 16, 2025Feb 19, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
41,65041,650Feb 14, 2025Feb 19, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
62,50062,500Feb 14, 2025Feb 19, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
739$56.39$41.7K105,556Feb 12, 2025Feb 14, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
12$56.22$675105,544Feb 12, 2025Feb 14, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,3430Feb 11, 2025Feb 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,291$57.51$74.2K106,300Feb 11, 2025Feb 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5$57.53$288106,295Feb 11, 2025Feb 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
2,343107,591Feb 11, 2025Feb 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
4,062105,248Feb 9, 2025Feb 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,0624,062Feb 9, 2025Feb 11, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
1,678$59.43$99.7K101,186Feb 4, 2025Feb 4, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,9259,850Feb 1, 2025Feb 4, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
4,925102,864Feb 1, 2025Feb 4, 2025View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
15,515$39.22$608.5K97,939Mar 19, 2024Mar 19, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
80,40080,400Feb 16, 2024Feb 21, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
26,40026,400Feb 16, 2024Feb 21, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
33,750113,454Feb 16, 2024Feb 21, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
709$49.82$35.3K79,704Feb 13, 2024Feb 13, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
1,209$51.38$62.1K80,413Feb 12, 2024Feb 13, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
2,34481,622Feb 11, 2024Feb 13, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,3442,343Feb 11, 2024Feb 13, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,0638,124Feb 9, 2024Feb 13, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
4,06379,278Feb 9, 2024Feb 13, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
4,92576,831Feb 1, 2024Feb 5, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,92514,775Feb 1, 2024Feb 5, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
1,616$45.06$72.8K75,215Feb 1, 2024Feb 5, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
10,500$6.88$72.2K71,906Dec 29, 2023Jan 3, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
10,500100,594Dec 29, 2023Jan 3, 2024View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
20,000$40.00$800.0K61,406Dec 6, 2023Dec 7, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
20,000111,094Dec 6, 2023Dec 7, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
20,000$6.88$137.6K81,406Dec 6, 2023Dec 7, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
7,026$35.06$246.4K61,406Dec 5, 2023Dec 7, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
7,026131,094Dec 5, 2023Dec 7, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
7,026$6.88$48.3K68,432Dec 5, 2023Dec 7, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
10,974138,120Nov 24, 2023Nov 28, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
10,974$6.88$75.5K72,380Nov 24, 2023Nov 28, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
10,974$35.02$384.3K61,406Nov 24, 2023Nov 28, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
12,000$6.88$82.6K73,406Nov 14, 2023Nov 16, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
12,000$30.38$364.6K61,406Nov 14, 2023Nov 16, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
12,000149,094Nov 14, 2023Nov 16, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,000161,094Jun 16, 2023Jun 21, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
2,000$6.88$13.8K61,406Jun 16, 2023Jun 21, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
702$26.87$18.9K59,406Feb 14, 2023Feb 14, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
2,34460,108Feb 11, 2023Feb 14, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,3444,687Feb 11, 2023Feb 14, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
1,398$27.66$38.7K57,779Feb 9, 2023Feb 13, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
4,06359,177Feb 9, 2023Feb 13, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,06312,187Feb 9, 2023Feb 13, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
1,413$27.51$38.9K57,764Feb 9, 2023Feb 14, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,70019,700Feb 1, 2023Feb 3, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
53,60053,600Feb 1, 2023Feb 3, 2023View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALEGRANT
Gift
2,50055,114Dec 23, 2022Dec 29, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
7,547$4.08$30.8K57,614Jul 1, 2022Jul 6, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
25,0000Jun 30, 2022Jul 6, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
25,00065,161Jun 30, 2022Jul 6, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
833$6.10$5.1K40,161Feb 15, 2022Feb 15, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
2,34440,994Feb 11, 2022Feb 15, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,3447,031Feb 11, 2022Feb 15, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
97,50097,500Feb 9, 2022Feb 11, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,25016,250Feb 9, 2022Feb 11, 2022View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
5,000163,094Apr 21, 2021Apr 23, 2021View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
5,000$6.88$34.4K38,650Apr 21, 2021Apr 23, 2021View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
56,25056,250Feb 11, 2021Feb 16, 2021View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
9,3759,375Feb 11, 2021Feb 16, 2021View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
4,000168,094Jan 19, 2021Jan 20, 2021View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
4,000$6.88$27.5K33,650Jan 19, 2021Jan 20, 2021View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jul 20, 2020Jul 21, 2020View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 30, 2020Jul 2, 2020View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
CFO and Interim CEO
3,900172,094Mar 30, 2020Mar 31, 2020View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
CFO and Interim CEO
3,900$6.88$26.8K29,650Mar 30, 2020Mar 31, 2020View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
3,500$6.88$24.1K25,750Mar 13, 2020Mar 16, 2020View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
3,500175,994Mar 13, 2020Mar 16, 2020View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
82,00082,000Feb 14, 2020Feb 19, 2020View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
6,250$6.88$43.0K22,250Jan 28, 2020Jan 29, 2020View →
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,250179,494Jan 28, 2020Jan 29, 2020View →
Other insiders · RYTM
Loading peer insiders…
About this filer
CIK 0001636385
ROLE
Chief Financial Officer
PRIMARY
RYTM
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001636385DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback